How is Hunter syndrome diagnosed?

Hunter syndrome, or Mucopolysaccharidosis type II (MPS II), is diagnosed through a combination of clinical evaluation, urine tests for glycosaminoglycans (GAGs), and definitive genetic testing to identify mutations in the IDS gene. Because it is a rare, progressive condition, early diagnosis is critical for accessing enzyme replacement therapies that can mitigate long-term complications.

How is Hunter syndrome diagnosed clinically?

The diagnostic process for Hunter syndrome typically begins when a pediatrician or specialist notices characteristic physical features or developmental delays. Because Hunter syndrome is a multisystem disorder, the diagnostic pathway often involves a "diagnostic odyssey," where families visit multiple specialists—such as cardiologists, neurologists, or orthopedists—before the underlying metabolic cause is identified. On average, rare disease patients may wait years for a definitive diagnosis, a process that can be incredibly isolating and exhausting for caregivers.

What tests confirm a diagnosis of Hunter syndrome?

Once Hunter syndrome is suspected, physicians utilize a specific diagnostic workflow to confirm the condition:

• Urinalysis: Screening for elevated levels of heparan sulfate and dermatan sulfate (GAGs).


• Enzyme Assay: Measuring the activity of the iduronate-2-sulfatase (I2S) enzyme in blood, serum, or skin fibroblasts; low activity confirms the diagnosis.


• Genetic Testing: Molecular analysis of the IDS gene is the gold standard to identify the specific mutation, which is essential for family planning and genetic counseling.

Which specialists are involved in the diagnosis?

A diagnosis of Hunter syndrome is usually coordinated by a clinical geneticist or a metabolic specialist. It is vital to seek care at a center of excellence, as general practitioners may rarely encounter this condition. If you feel your concerns are being dismissed, do not hesitate to seek a second opinion from a metabolic center. At DiseaseMaps.org, 66 people with Hunter syndrome have shared their journeys, highlighting the importance of connecting with others who understand the complexities of this rare disease.

What conditions mimic Hunter syndrome?

Hunter syndrome is often initially confused with other mucopolysaccharidoses, particularly Hurler syndrome (MPS I), due to overlapping physical symptoms like coarse facial features, skeletal abnormalities, and organ enlargement. Differentiating these requires precise biochemical and genetic testing, as treatment pathways differ significantly.

Next steps

• Consult a metabolic geneticist to review clinical symptoms and order diagnostic testing.


• Request a referral to a center specializing in lysosomal storage disorders.


• Connect with the 66 members of our Hunter syndrome community at DiseaseMaps.org to share experiences and find emotional support.

Medical disclaimer: This content is for informational purposes only and does not replace professional medical advice, diagnosis, or treatment from a qualified healthcare provider.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Hunter syndrome overview.


• Orphanet: Mucopolysaccharidosis type II (MPS II).


• OMIM (Online Mendelian Inheritance in Man): Mucopolysaccharidosis type II; MPS2.


• National MPS Society: Educational resources for patients and families.